August 21, 2012 - The popular blood thinner Pradaxa has been associated with severe and sometimes fatal internal bleeding. Now, those patients affected will have the right to seek recovery after a federal judge ruled lawsuits against the manufacturer can proceed.Read More
August 8, 2012 – Two weeks after hearing arguments from several lawyers involved in the current Pradaxa bleeding lawsuits, the Judicial Panel on Multidistrict Litigation today issued an order consolidating the outstanding cases to the MDL court in the Southern District of Illinois.Read More
July 31, 2012 - Patients who suffered internal bleeding after taking the drug Pradaxa should soon know where and how injury claims filed by hundreds with similar injuries will be handled now that a federal panel has heard arguments from both sides.Read More
Pradaxa is an anticoagulant that has been used to treat people that have an irregular heartbeat or atrial fibrillation by helping to prevent strokes and serious blood clots.
In the few short years it has been on the market it has been prescribed to millions of people.
Boehringer Ingelheim, the maker of Pradaxa has advertised it to be a more effective and safer alternative to Coumadin. However, reports and clinical trials sent to the FDA argue that Pradaxa may cause an increased risk of hemorrhaging and serious or fatal internal bleeding.
The FDA announced in December 2011, that it would initiate an investigation into the safety of Pradaxa amid extensive reports of internal bleeding that had led to death among patients.
This follows warnings by regulators in Australia, Japan and Europe.
Expert attorneys are currently assisting those who have been afflicted by an injury or death due to Pradaxa and helping them to file a claim for their loss.
If you or a loved one have been the victim of an injury or death after taking Pradaxa, Learn about the legal options available to you by speaking with a qualified attorney.
|Internal Bleeding||Local Help||Legal Options|
September 24, 2012 – With experts linking the blood thinner Pradaxa to severe internal bleeding and hundreds filing lawsuits for injury or death, a federal judge recently scheduled an initial hearing and indicated when trials would begin.
If you have been affected by internal bleeding or the loss of a loved one from Pradaxa, it is important to speak with a lawyer about your legal options as soon as possible. You may be entitled to substantial compensation.
Pradaxa is a popular anticoagulant drug prescribed to stop strokes and blood clots in patients with atrial fibrillation. Although only on the market since October, 2010, the drug has earned over $1 billion for manufacturer Boehringer Ingelheim and has been used in over 70 countries.Read More
September 5, 2012 – As the maker of Pradaxa issued a report last month that use of the drug had reached record levels, a federal judge ruled that they will have to face the potential of thousands of injury and death lawsuits over internal bleeding side effects.
If you have been affected by internal bleeding or the loss of a loved one from Pradaxa, it is important to speak with a lawyer about your legal options as soon as possible.
Pradaxa is a popular blood thinner prescribed to prevent strokes and blood clots in those with atrial fibrillation. On August 27, 2012, manufacturer Boehringer Ingelheim issued an announcement that the drug has now been prescribed for one million patient-years of combined time, and has been used in over 70 countries worldwide.Read More
Pradaxa was originally approved for use in Europe in 2008 and in the United States in 2010. The drug was endorsed by the American Heart Association as well as the American College of Cardiology Foundation for non valvular atrial fibrillation in February 2011. After these endorsements the use of Pradaxa soared, however, with this increased use of Pradaxa came detrimental events.
The reporting service of the FDA MedWatch reported that they received several hundred complaints of severe internal bleeding that led to death in some cases.
The FDA's MedWatch had also attributed the use of Pradaxa to more adverse events than nearly 99% of other drugs on the market. Some of the dangerous and even potentially fatal events associated with Pradaxa are:
There have been numerous episodes reported by doctors in which patients taking Pradaxa bled to death, due to the fact that there is no reversal agent for this drug as there is for other anticoagulants such as Coumadin and Wayfarin.
On December 7, 2011 the FDA indicated that they were evaluating reports of serious and or fatal bleeding events in patients taking Pradaxa.
Due to the fact that the makers of Pradaxa failed to warn patients of the grave side effects of the drugs as well as the lack of treatment available to combat these side effects, they are now facing thousands of lawsuits.
Contact us now to see what your legal options are, as well as to learn more about the side effects of Pradaxa. We are available to answer your questions and provide you with help 24 hours a day.
Authored by Chris Schroeder